Format

Send to

Choose Destination
See comment in PubMed Commons below
Interact Cardiovasc Thorac Surg. 2010 Jul;11(1):83-5. doi: 10.1510/icvts.2010.234625. Epub 2010 Apr 15.

Which available transapical transcatheter valve fits into degenerated aortic bioprostheses?

Author information

1
Department of Cardiovascular Surgery, University Hospital of Lausanne CHUV, CH-1011 Lausanne, Switzerland. enricoferrari@bluewin.ch

Abstract

The transapical transcatheter aortic valve implantation (TA-TAVI) in degenerated aortic bioprosthesis is an emerging therapy for surgically non-amenable patients. However, the presence of different types of aortic bioprostheses (stented and stentless), available in different sizes (19-27 mm), can be at the origin of important mismatches between the malfunctioning, degenerated aortic valves and the inner stent-valves implanted through transapical accesses (23 and 26 mm Edwards Sapien transcatheter stent-valves). We report an emergency TA-TAVI treatment of a severely regurgitant degenerated 23 mm Mitroflow aortic bioprosthesis (Sorin Group, Milano, Italy) implanted seven years earlier in an 80-year-old lady, and we reviewed the current available literature about transapical 'valve-in-valve' procedures to analyze the hemodynamic results and the ideal 'prosthesis-to-prosthesis' match.

PMID:
20395247
DOI:
10.1510/icvts.2010.234625
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Silverchair Information Systems
    Loading ...
    Support Center